RU2012111059A - METHOD FOR PREDICTING THE TREATMENT EFFICIENCY AND TREATMENT OF THE TUMOR PROCESS IN PATIENTS WITH CANCER OF THE RINGER - Google Patents
METHOD FOR PREDICTING THE TREATMENT EFFICIENCY AND TREATMENT OF THE TUMOR PROCESS IN PATIENTS WITH CANCER OF THE RINGER Download PDFInfo
- Publication number
- RU2012111059A RU2012111059A RU2012111059/15A RU2012111059A RU2012111059A RU 2012111059 A RU2012111059 A RU 2012111059A RU 2012111059/15 A RU2012111059/15 A RU 2012111059/15A RU 2012111059 A RU2012111059 A RU 2012111059A RU 2012111059 A RU2012111059 A RU 2012111059A
- Authority
- RU
- Russia
- Prior art keywords
- patients
- treatment
- course
- volume
- values
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract 8
- 238000000034 method Methods 0.000 title claims abstract 8
- 201000011510 cancer Diseases 0.000 title 1
- 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 claims abstract 4
- 206010061306 Nasopharyngeal cancer Diseases 0.000 claims abstract 4
- 201000010099 disease Diseases 0.000 claims abstract 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract 4
- 238000004393 prognosis Methods 0.000 claims abstract 4
- 230000002349 favourable effect Effects 0.000 claims abstract 2
- 230000002489 hematologic effect Effects 0.000 claims abstract 2
- 210000004698 lymphocyte Anatomy 0.000 claims abstract 2
- 210000000440 neutrophil Anatomy 0.000 claims abstract 2
- 210000005259 peripheral blood Anatomy 0.000 claims abstract 2
- 239000011886 peripheral blood Substances 0.000 claims abstract 2
- 238000011127 radiochemotherapy Methods 0.000 claims abstract 2
- 208000024891 symptom Diseases 0.000 claims abstract 2
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Способ прогнозирования эффективности лечения и течения опухолевого процесса у больных раком носоглотки, включающий гематологическое исследование и отличающийся тем, что до начала химиолучевого лечения и перед каждым последующим курсом у больных раком носоглотки III-IV стадии определяют в периферической крови значения коэффициентов отношения среднего объема нейтрофилов и среднего объема лимфоцитов к их абсолютному количеству: MVNe/#Ne и MVLy/#Ly и при значениях коэффициентов свыше 45 констатируют генерализацию опухолевого процесса и отрицательный прогноз течения заболевания при отсутствии клинических признаков манифестации, а при значениях указанных коэффициентов ниже 45 констатируют отсутствие генерализации опухолевого процесса и благоприятный прогноз течения заболевания.A method for predicting the effectiveness of treatment and the course of the tumor process in patients with nasopharyngeal cancer, including a hematological study and characterized in that before the start of chemoradiotherapy and before each subsequent course in patients with nasopharyngeal cancer of the III-IV stage, the values of the ratios of the ratio of the average neutrophil volume and the average volume are determined in peripheral blood the volume of lymphocytes to their absolute number: MVNe / # Ne and MVLy / # Ly and when the coefficient values are over 45, generalization of the tumor process is noted and negative ny prognosis of the disease in the absence of the manifestation of clinical symptoms, and for the values of said coefficients below 45 ascertain the absence of tumor generalization favorable prognosis and course of the disease.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012111059/15A RU2526830C2 (en) | 2012-03-22 | 2012-03-22 | Method for prediction of clinical effectiveness and clinical course of neoplastic process in patients with nasopharyngeal carcinoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012111059/15A RU2526830C2 (en) | 2012-03-22 | 2012-03-22 | Method for prediction of clinical effectiveness and clinical course of neoplastic process in patients with nasopharyngeal carcinoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2012111059A true RU2012111059A (en) | 2013-11-20 |
| RU2526830C2 RU2526830C2 (en) | 2014-08-27 |
Family
ID=49554880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2012111059/15A RU2526830C2 (en) | 2012-03-22 | 2012-03-22 | Method for prediction of clinical effectiveness and clinical course of neoplastic process in patients with nasopharyngeal carcinoma |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2526830C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2622756C1 (en) * | 2016-02-15 | 2017-06-19 | Дмитрий Юрьевич Мельников | Method for oncological diseases course prediction |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2021620C1 (en) * | 1991-08-12 | 1994-10-15 | Франциянц Елена Михайловна | Method of determination of antitumorigenic therapy effectiveness |
-
2012
- 2012-03-22 RU RU2012111059/15A patent/RU2526830C2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2526830C2 (en) | 2014-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201400855A1 (en) | MONOCLONAL HUMAN ANTIBODIES OBTAINED FROM HUMAN B-CELLS AND HAVING NEUTRALIZING ACTIVITY AGAINST THE VIRUS AIRFLOWER | |
| EA201790719A1 (en) | BISPECIFIC MONOVALENT DIATELS, WHICH ARE CAPABLE TO BIND CD19 AND CD3, AND THEIR APPLICATION THEREOF | |
| EA201500314A1 (en) | DOSAGE FORMS OF ENZALUTAMIDE | |
| EA201201030A1 (en) | 5-Alkinylpyrimidines | |
| RU2017112747A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A DEXTROMETORPHANIC COMPOUND AND QUINIDINE FOR THE TREATMENT OF EXCITATION IN DEMENIUM | |
| EP2753348A4 (en) | PHARMACEUTICAL COMPOSITION USED IN THE TREATMENT OF CANCER, COMPRISING A CONJUGATE OF THE INTERFERON ALPHA | |
| EA201400274A1 (en) | CONNECTING MOLECULE THAT HAS NEUTRALIZING ACTIVITY AGAINST THE VIRUS OF THE INFLUENZA VIRUS, RECEIVED FROM H-CELLS | |
| RU2013149168A (en) | ANALOGUES OF EPOXYEOSOCATRENIC ACID AND METHODS FOR PRODUCING AND USING THEM | |
| EA201491546A1 (en) | GAS TREATMENT SYSTEM WITH USE OF SUPER SOUND SEPARATORS | |
| EP2633865A4 (en) | USE OF INTERLEUKINE 22 IN THE TREATMENT OF VIRAL HEPATITIS | |
| EA202191133A1 (en) | TYPE I INTERFERON SIGNATURES AND METHODS OF THEIR APPLICATION | |
| EA201791960A1 (en) | APPLICATION OF LEMON-ACID IRON IN THE TREATMENT OF THE CAUSED DEFICIENCY OF THE IRON ANEMIA | |
| EP2709618A4 (en) | METHODS FOR THE TREATMENT AND DIAGNOSIS OF PULMONARY ARTERIAL HYPERTENSION | |
| RU2012111059A (en) | METHOD FOR PREDICTING THE TREATMENT EFFICIENCY AND TREATMENT OF THE TUMOR PROCESS IN PATIENTS WITH CANCER OF THE RINGER | |
| EP2774634A8 (en) | Dialysis machine with a self-supporting machine housing | |
| JP2013201655A5 (en) | ||
| RU2012100291A (en) | METHOD FOR EVALUATING PANT PERFORMANCE OF REDUCER MARAL | |
| RU2009125095A (en) | METHOD FOR DETERMINING HEMOSTIMUSULATOR EFFICIENCY AT CYTOSTATIC MYELOSPRESSION | |
| MA38156B1 (en) | Use of pidotimod to treat atopic dermatitis | |
| RU2012112098A (en) | METHOD FOR INCREASING SURGERY OF THE SKIN FLAP IN THE CONDITIONS OF REDUCED BLOOD CIRCULATION BY MINOXIDYL | |
| RU2008152470A (en) | METHOD FOR PREDICTING THE EFFECTIVENESS OF CHEMI-RADIATION THERAPY IN PATIENTS WITH DISSEMINATED MELANOMA SKIN | |
| RU2015134525A (en) | METHOD FOR PREDICTING EFFECTIVENESS OF TREATMENT OF PATIENTS WITH CERVICAL CANCER RECIDITIES | |
| RU2009111724A (en) | METHOD FOR PREDICTING CONTENT IN PERIPHERAL BLOOD OF PREGNANT Arachidonic Acid in Exacerbation of Herpes Virus Infection | |
| RU2015104076A (en) | COMPOSITION WITH FACTORS OF GROWTH FOR APPLICATION IN THE INTRANASAL TREATMENT OF A NEURODEGENERATIVE DISEASE OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM AND METHOD FOR PRODUCING IT | |
| MA35029B1 (en) | TREATMENT OF HEPATITIS C VIRUS INFECTION WITH ALISPORIVIR |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20140120 |
|
| HC9A | Changing information about author(s) | ||
| FZ9A | Application not withdrawn (correction of the notice of withdrawal) |
Effective date: 20140319 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140815 |